Centessa Pharmaceuticals plc (CNTA) — Stock Score Summary

Centessa Pharmaceuticals plc (CNTA) has a MoatMap StockRank of 48/100 based on Quality (32/100), Value (33/100), and Momentum (70/100) factor scores. The current signal is HOLD. Centessa is a asset-light biotech developer whose pipeline progression could be slowed or made more expensive by the tightening capacity and rising pricing power of top-tier CDMOs.

Centessa Pharmaceuticals plc is a clinical-stage biopharmaceutical company operating with an 'asset-centric' model, focused on developing a diversified pipeline of novel therapies for various diseases. The company aims to accelerate drug development by advancing promising drug candidates sourced from academic institutions and other biotechs. This diversified, project-focused approach seeks to mitigate risk and efficiently bring innovative medicines to patients.

Key Financial Metrics

Price$39.76
Market Cap$6.2B
P/E (Forward)-20.97
Price/Book12.63
Return on Equity-57.4%
Return on Invested Capital-28.6%
Debt/Equity24.33
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-129M

Centessa Pharmaceuticals plc operates in the Biotechnology industry, part of the Healthcare sector (United Kingdom).

Frequently Asked Questions

What is Centessa Pharmaceuticals plc’s (CNTA) StockRank?
MoatMap’s StockRank for Centessa Pharmaceuticals plc (CNTA) is 48/100, with a Hold signal. It is a composite of Quality (32), Value (33), and Momentum (70) factor ranks across MoatMap’s 19,000+ stock universe.
Does Centessa Pharmaceuticals plc have an economic moat?
Centessa Pharmaceuticals plc (CNTA) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Centessa Pharmaceuticals plc a buy, hold, or sell?
MoatMap’s current signal for Centessa Pharmaceuticals plc (CNTA) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Centessa Pharmaceuticals plc in?
Centessa Pharmaceuticals plc (CNTA) operates in the Healthcare sector, specifically the Biotechnology industry (United Kingdom).
Browse all ranked stocksCNTA deep dive reportAI ChampionsHow we score stocksSense-check another stock